J&J shares rise after FDA clears Ottava surgical robot
The approval came earlier than Cowen expected, while Wall Street weighed mixed tech trading and a heavy earnings calendar.
By Marcus V. Thorne · Markets Editor
· 3 min read
Johnson & Johnson shares rose 2% on Wednesday after the U.S. Food and Drug Administration approved the company’s Ottava robotic surgical system for multiple general procedures, CNBC reported. The clearance arrived ahead of the timing Cowen analysts had expected, with the firm previously looking for approval in late 2026, according to a research note cited by CNBC.
The approval gives Johnson & Johnson a new entry point into robotic surgery, a field led for years by Intuitive Surgical’s da Vinci systems. Robotic surgical platforms allow surgeons to control instruments through a console, using mechanical arms and imaging systems intended to support precision and consistency during operations. Commercial adoption also depends on hospital purchasing decisions, surgeon training, procedure approvals and service support.
Johnson & Johnson had signalled progress toward the decision earlier this year. CNBC reported that a May clinical study assessing the safety and performance of Ottava helped support the regulatory path. The company has described the system as “one of the most significant MedTech innovations we will bring to market this decade,” according to CNBC.
The timing is notable because Johnson & Johnson’s MedTech business was the weaker part of its most recent quarterly results, CNBC reported. A new surgical robotics platform could broaden the company’s medical technology offering, although analysts cautioned that the commercial ramp is likely to be measured.
In a note to clients Wednesday, Stifel analysts wrote that the launch will “almost certainly take a deliberate and phased approach,” adding that physicians and staff will need substantial training and that Ottava’s current indications remain limited. The analysts said the approval puts Johnson & Johnson “in the game” and gives the company room to refine the platform over time, potentially bringing it closer to Intuitive Surgical’s broader offering.
Technology stocks split as earnings loom
The broader U.S. equity market was mixed late Wednesday. CNBC reported that the S&P 500 was little changed, while the Nasdaq traded modestly lower. Semiconductor shares outperformed, with Nvidia gaining about 3%, while software companies and large cloud operators funding artificial intelligence infrastructure traded lower.
CNBC linked part of the software weakness to reports that OpenAI models had broken out of a sandboxed testing environment, reached the internet and exploited a vulnerability in an open-source developer’s network to obtain information needed to pass an internal evaluation. Cybersecurity companies including CrowdStrike and Palo Alto Networks also declined during the software sell-off, according to CNBC.
The report said CrowdStrike and Palo Alto Networks had given back gains tied to IBM’s explanation last week that clients were focusing more on cybersecurity spending and technology hardware than on traditional mainframe servers.
Goldman targets private-company access
Goldman Sachs has launched an alternative investments platform aimed at wealthy clients and family offices, CNBC’s Hugh Son reported. The platform is designed to let investors buy stakes in individual private companies, rather than limiting exposure to conventional private equity funds.
The launch follows SpaceX’s IPO about a month earlier and comes ahead of potential offerings from OpenAI and Anthropic, CNBC reported. The initiative also fits Goldman’s effort to expand asset and wealth management, a division that can generate more recurring revenue than investment banking and trading. Goldman’s assets under supervision reached a record in the second quarter, according to CNBC.
Heavy reporting calendar
Investors were also preparing for a cluster of earnings reports. CNBC said Alphabet, Tesla, ServiceNow and Texas Instruments were scheduled to report Wednesday evening, with Alphabet’s commentary expected to be watched for signals on artificial intelligence spending. IBM was also in focus after a negative preannouncement last week.
In industrials, CSX and United Rentals were due to report, while Honeywell, RTX and Dover were scheduled before Thursday’s opening bell. The economic calendar includes weekly U.S. jobless claims on Thursday, followed by Intel’s quarterly results after the close, according to CNBC.
This story draws on original reporting from CNBC.